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ABSTRACT End-stage renal disease (ESRD) patients probably represent the
most difficult group of patients vascular surgeons are called upon to treat for
critical limb ischemia. Advanced lower extremity arterial occlusive disease and
frequent comorbidities make infrainguinal arterial bypass grafting (IABG) in
this population both technically and medically challenging. Results of IABG
are far inferior to those in non-ESRD patients. The greatest limitation to limb
salvage appears to be progressive tissue necrosis and infection despite a patent
bypass graft, a problem nearly unique to ESRD. Clinical predictors of outcome
for IABG in this population have not been well established. The site and extent
of tissue loss, the presence of associated infection, and the degree of pedal level
occlusive disease have been identified as potentially important predictors.
Improving outcome for ESRD patients with critical limb ischemia requires the
establishment of firm guidelines for IABG to avoid futile and risky attempts at
bypass in individuals better served by primary amputation.
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Current techniques of infrainguinal arterial bypass grafting (IABG) have
allowed vascular surgeons to maintain limb viability and restore function in a
large percentage of patients presenting with critical limb ischemia. Coupled
with forefoot amputations and innovative procedures for tissue coverage,
IABG can save many limbs previously deemed unsalvageable. Nevertheless,
there exist certain patients for whom the benefits of arterial reconstruction
are less obvious and for whom primary amputation may provide a more log-
ical approach. Patients with end-stage renal disease (ESRD) represent one of
the most frequently encountered subsets of patients with critical limb
ischemia in whom the decision to bypass or amputate can be especially chal-
lenging, even for the most experienced vascular surgeon.
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ESRD is defined as a state of native renal function that necessitates renal
replacement therapy (hemodialysis, peritoneal dialysis, or renal transplanta-
tion) for survival. Patients with ESRD currently comprise only a small pro-
portion of patients undergoing lower extremity arterial reconstructions (6%
in our institution), but this may change dramatically in the future. In 1998,
approximately 300,000 patients were receiving renal replacement therapy in
the United StatesB that number is growing at an annual rate 6 to 7%2 and will
reach an estimated 600,000 patients by 2010.~ The greatest increase in treat-
ment with long-term dialysis has been among the elderly and those with dia-
betes, two groups at high risk for peripheral arterial occlusive disease
(PAOD).4,5 In addition, over the last 2 decades, the life expectancy of dialysis
patients has slowly improved, resulting in an older population with poten-
tially more advanced atherosclerotic disease.4 These data suggest an increas-
ing burden of PAOD in patients with ESRD and a concomitant rise in future
demand for arterial reconstruction.
Since the late 1980s, ESRD patients with critical limb ischemia undergo-
ing IABG have been recognized as a subgroup with inferior graft patency and
limb salvage compared to others treated with infrainguinal bypass.’ In addi-
tion, the comorbidities frequently associated with ESRD (e.g., diabetes,
hypertension, and coronary artery disease) have an adverse effect on opera-
tive outcome as well as long-term survival.~ Amputation, however, may not
represent a &dquo;safe&dquo; alternative for these patients as the mortality for lower
extremity amputation in this population is substantial.$ The question vascular
surgeons must consider is whether the results of IABG in this group justify
the risks to the patient and the expense to the health care system.
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
Although good data are lacking on the incidence of PAOD in ESRD, extrapo-
lation from coronary artery disease data would suggest a prevalence far in
excess of that in patients without renal failure. Almost half of all deaths in
ESRD patients are caused by cardiovascular disease, with cardiac arrest, acute
myocardial infarction, and arrhythmia as the leading causes.’ The aggressive
atherosclerosis present in many of these patients is the result of a number of
well-established risk factors frequently associated with chronic renal failure:
diabetes mellitus, hypertension, hyperlipidemia, hyperhomocystinemia, and
advancing age. Diabetes mellitus or primary hypertension together account for
almost two thirds of cases of ESRD.3 In addition, secondary hypertension
occurs with many renal disorders and is nearly universal by the time dialysis is
initiated. Lipid disturbances are common with chronic renal failure (uremic
dyslipidemia) and are characterized by elevated levels of total cholesterol,
lipoprotein (a), and triglycerides and reduced levels of high-density lipopro-
tein. This atherogenic lipid profile is further heightened by enhanced oxidation
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Fig. 1 Angiograms of diabetic ESRD patient with absent toe pressures and forefoot
gangrene. (A) The arterial circulation is in continuity to the pedal level with typical
&dquo;pruning&dquo; of the distal tibial vessels. (B) The pedal vasculature is severely affected,
and only diseased short segments of major vessels can be identified.
of low-density lipoprotein in uremia.10,11 Increased plasma levels of homocys-
teine has recently been recognized as an independent risk factor for athero-
sclerosis, and studies have consistently documented elevated concentrations of
homocysteine in chronic renal failure, particularly in patients on hemodialy-
sis.12,13 Other factors that may play a role in the accelerated atherogenesis of
chronic renal failure include secondary hyperparathyroidisn1 and chronic
endothelial activation and injury with release of prothrombotic factors. 14,15
Smoking is especially dangerous in ESRD patients, particularly diabetics in
whom smoking more than doubles the rate of lnyocardial infarction.16
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The pattern of lower extremity atherosclerosis associated with chronic
renal failure is somewhat unusual and appears to be less favorable for inter-
vention. Although never rigorously defined in the literature, there is a general
recognition that patients with ESRD have more severe and more distal lower
extremity occlusive disease, particularly at the pedal level, than PAOD
patients without ESRD (Fig. 1 A,B). Part of this difference is undoubtedly
due to the high incidence of concurrent diabetes mellitus and its well-
documented association with distal disease, although patients with chronic
renal failure seem to have even more occlusive disease in the pedal vasculature.
Extensive calcification in the media of large, medium, and small arteries is
another prominent but not fully understood component of the arteriopathy
of ESRD .17 Tibial artery calcification makes accurate interpretation of seg-
mental limb pressures impossible in this population and can make IABG
technically challenging if not occasionally impossible. The presence of
uremia-induced microcirculatory changes has been suggested, although at
present there is limited evidence of such derangements only in the coronary
microcirculation.11
WOUND HEALING
Poor wound healing and infection are frequent problems in most reports of
IABG for critical limb ischemia in ESRD patients. Difficulties occur not only
at the site of presenting tissue loss on the foot but also at incision sites for
arterial reconstruction. These problems are frequently ascribed to as-yet
unproved small artery disease but probably result from a number of factors.
Uremia is a well-established cause of impaired wound healing&dquo; as are diabetes
mellitus, anemia, and malnutrition, which are frequent comorbidities in this
population. Altered immune activity, including impaired neutrophil chemo-
taxis and macrophage function, results from renal failure and undoubtedly
plays a role in the reduced ability of these patients to fight infection.&dquo; Poor
wound healing and inability to contain infection can lead to limb loss despite
a functioning bypass, an all-too-frequent complication in many published
series. Renal replacement therapy with transplantation avoids many of the
problems associated with dialysis (e.g., uremia and anemia), but requires
pharmacologic immunosuppression with all its attendant risks for wound
healing and infection.
TECHNICAL PROBLEMS ASSOCIATED WITH BYPASS GRAFTING
There are a number of technical problems associated with lower extremity
arterial reconstruction in ESRD patients. The pattern of disease is such that
very distal arteries are the best and commonly the only targets for bypass.
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The severe calcification frequently present can challenge even the most profi-
cient surgeon. In situations where tourniquet control is impossible, the uti-
lization of intraluminal occluders may be necessary to avoid clamp injury of
calcified distal arteries. The frequency of postoperative incisional complica-
tions mandates meticulous surgical technique with avoidance of excessive flap
undermining and skin bridges. Upper extremity veins are usually not available
for bypass conduits or are avoided because of concerns over future dialysis
access. Postoperatively, these patients require a high level of maintenance
with careful follow-up and frequent wound debridements and/or local foot
amputations for successful limb salvage.
RESULTS OF INFRAINGUINAL ARTERIAL BYPASS GRAFTING
Published series of ESRD patients undergoing IABG are summarized in Table
l .6,20-32 Diabetes mellitus and hypertension were frequent comorbidities. Peri-
operative mortality in these reports was substantial, averaging 8.6% (range 0 to
27%), higher than the 2 to 3% mortality rate quoted in the best series of non-
ESRD patients. The most common cause of death was myocardial infarction.
Perioperative morbidity was also high, and wound complications accounted
for the majority, with an incidence between 17 and 54%. Only 2-year patient
survival and limb salvage outcomes are presented because the recognized mor-
tality of ESRD precludes meaningful analysis beyond this point. Patient
survival at 2 years averaged 49% (range 38 to 62%), a low survival even for
ESRD patients, but a reflection of the severity of associated comorbidities in
this population. Two-year limb salvage varied substantially from a low of 50%
to a high of 91%. This wide variability is confusing but important to under-
stand in assessing the role of bypass grafting in this high-risk group.
Further analysis of these series reveals two rather distinct time periods
based on outcome (Table 2). The reports from 1988 to 1993 are character-
ized by an excellent 2-year limb salvage rate of 79% (range 71 to 91%). In
contrast, the 1994 to 1998 series have a much lower average salvage rate of
57% (range 50 to 62%). These data appear to demonstrate worsening IABG
results in ESRD patients in the latter part of this decade. Selection and/or
reporting bias may partially explain this incongruity, but closer inspection
reveals a more likely cause. The patients reported in the later series were older
and more frequently diabetic, and by analysis of distal target site appeared to
have a greater burden of disease (Table 2). Prior to 1994, bypass was per-
formed to the tibial arteries or lower only 31% of the time (61 of 199 limbs
reported); however, in the later interval (1994 to 1998) a tibial or pedal
artery was chosen in 71% (198 of 278 limbs) of reconstructions. The older
age and increasing prevalence of diabetes in patients undergoing IABG in the












































patients in general.’ Current results may simply reflect an older, sicker, and
more diseased operative cohort.
Limb salvage rates are generally expected to equal or slightly exceed graft
patency rates in most IABG reports. However, review of these ESRD series
reveals that technical success of the bypass procedure frequently did not
equate with limb salvage. In fact, of the 142 amputations performed in these
collected reports, 65 (46%) were performed in the presence of a functioning
graft. Thus, roughly 14% of all infrainguinal reconstructions performed in
ESRD limbs will end in amputation despite a patent bypass. Edwards and col-
leagues were the first to call attention to this phenomenon in 1988; 26% of
their ESRD patients required an amputation with a patent graft compared
with only 6% of non-ESRD patients with a functioning bypass.’ Since this ini-
tial report, nearly every large series has documented a similar disappointing
outcome in a significant number of patients. 21-12 Most recently Hakaim and
colleagues reviewed their diabetic patients undergoing IABG and found that
the amputation rate in the presence of a functioning bypass was significantly
higher in ESRD diabetics than in those without renal disease (16% vs 2%). 31
Lower extremity amputation in the presence of a patent bypass may reflect
the choice of an inappropriate distal target artery that does not provide in-
line pulsatile flow to the foot. The increasing use of more distal vessels in the
1994 to 1999 era, however, argues against this explanation. Most telling in
this regard is the report of Leers et al. in which all patients underwent pedal
bypass grafting for tissue loss.32 Despite performance of a bypass that guaran-
teed pulsatile flow to the foot, 22% of limbs came to amputation with a
patent graft. Limb loss in this setting most frequently results from progressive
distal necrosis with continued sepsis.6,22,24,26.3o,32 A less common cause is inci-
sional breakdown and infection with graft exposure requiring graft liga-
tion. 1,32 Indeed, fear of this devastating complication has led some groups to
advocate anatomic tunneling of infrainguinal grafts in ESRD patients in place
of the in situ technique.’ In either situation of limb loss with a patent graft,
problems arise from an inability to heal wounds and clear infection. These
Table 2 Results of Infrainguinal Arterial Bypass Grafting in ESRD Based on Era
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data strongly suggest that tissue perfusion and/or wound healing in ESRD
patients is impaired well beyond that expected from diabetes alone.31
Graft thrombosis rates are not carefully detailed in many of the early ESRD
series. Review of later reports where these data are available reveals an aver-
age graft thrombosis rate of 14%, most within the first 2 years.6,20-32 Although
rates are higher than in most series of non-ESRD patients, they are not exces-
sive. The reason for this somewhat higher graft failure rate is unclear. A com-
monly voiced concern is an increased risk of graft thrombosis during the
occasional, unavoidable episodes of hypotension associated with hemo-
dialysis. To date, however, there have been few data in the literature docu-
menting the occurrence of this problem.
PREDICTORS OF OUTCOME
Most amputations with hemodynamically functioning bypass grafts occur
within the first few months following arterial reconstruction. Thus, these
high-risk patients are subjected to double jeopardy-the perioperative risks
of the bypass procedure and then the amputation-during a relatively short
time interval. The benefits of avoiding an unsuccessful attempt at limb
salvage are obvious. Several preoperative factors that adversely impact limb sal-
vage after IABG have been identified in the literature, including preopera-
tive infection,&dquo; ankle-brachial index < 0.3,~ poor systemic state/9 and
history of smoking.32 However, none of these factors appears to be a suffi-
ciently strong enough predictor to withhold IABG in otherwise suitable
candidates. The degree and location of pedal tissue loss have been particu-
larly closely studied to identify the patient subgroup with a high likelihood
of amputation even with technically successful bypass grafting. Edwards et
al. identified large (>2 cm in diameter) ischemic ulcerations in diabetic
ESRD patients as a bad prognostic sign.’ Heel or hindfoot gangrene,
defined as full-thickness skin loss >4 cm in diameter, was demonstrated by
Leers et al. to be a strong negative predictor for both limb salvage and sur-
vival.32 Even forefoot gangrene, defined as tissue loss beyond the web space
of the toes, has been associated with early clinical failure.3° Although all of
these tissue loss predictors seem reasonable, none has been validated in a
subsequent large-scale study.
THE HENRY FORD EXPERIENCE
To define preoperative factors that might predict the success or failure of
IABG in this high-risk group, we recently reviewed our 13-year experience
with 53 ESRD patients undergoing 64 infrainguinal bypasses. Patient demo-
graphics were similar to those of previously published reports (Table 1).
Ninety-one percent of the reconstructions were performed with autogenous
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vein, and the distal target was a tibial or pedal vessel in 67%. All but one
patient underwent arterial reconstruction for critical limb ischemia. Perioper-
ative mortality was 6.2%; three of four postoperative myocardial infarctions
were fatal. There were seven significant operative wound complications
(13%). The mean duration of follow-up was 22.2 months. At 24 months limb
salvage was 52% (7.4% SE), and patient survival was 61% (7.3% SE). There
were 24 amputations during follow-up-7 (29%) were performed for graft
failure and 17 (71%) were performed for uncontrolled infection or progres-
sive tissue loss, despite a patent graft. Fifteen of these 17 amputations
occurred within 6 months of IABG.
To evaluate the contribution of pedal level occlusive disease to the phe-
nomenon of amputation with a patent bypass, the arteriograms of 60 of the
64 reconstructions were reviewed, and the pedal runoff was scored using a
modified grading scale from 0 to 3 (0 reflecting normal pedal runoff and 3
reflecting no named pedal artery patent) as described in the joint vascular
surgery societies’ revised reporting standards for lower extremity ischemia.33
This pedal angiographic resistance score (PARS) was included in an evalua-
tion of factors that might influence limb salvage.
Univariate analysis identified several preoperative factors that adversely
impacted limb salvage: age less than 65 years (p < 0.018, hazard coefficient
4.74), preoperative toe pressures less than or equal to 20 mmHg (p < 0.025,
hazard coefficient 2.68), and PARS of 2.5 or greater (p < 0.008, hazard coef-
ficent 3.14). Smoking, extent of tissue loss, and race were of no significance,
although our policy during the latter half of the study period was to not offer
patients with extensive tissue loss IABG.
Age less than 65 years as a significant predictor of poor limb salvage is a
new finding and may represent more aggressive attempts at limb salvage in
younger patients rather than factors present in the limb. The findings that
low preoperative toe pressures and a high PARS predict inferior limb salvage
in this group are important. By objectively quantitating the extent of occlu-
sive disease in the foot, these measures may predict a patient’s ability to heal
pedal wounds with a functioning graft. Because the outcome most limiting
limb salvage in this group is progressive foot necrosis/infection in the pres-
ence of patent bypass, this information could significantly improve IABG
results by avoiding revascularization in patients with little chance of success.
Application of these selection criteria (age < 65 years, low preoperative toe
pressures, and high PARS) to the patients in our series would have targeted
12 of 64 limbs for primary amputation rather than bypass. In this group of
12 patients, only 2 had sustained graft patency and limb salvage at 1 year, and
1 of these still has an unhealed heel ulcer at 21 months and is nonambulatory.
One patient expired 11 months after reconstruction, 7 underwent amputa-
tion with patent bypass grafts within 5 months, and 2 others thrombosed
their grafts and underwent amputation within the first year.
90
JUSTIFICATION OF INFRAINGUINAL ARTERIAL BYPASS GRAFTING
Expected graft patency, limb salvage, and survival following IABG in the
ESRD population have been reasonably well established in the recent litera-
ture. Available data suggest a perioperative mortality of 9%, a graft thrombo-
sis rate of 14%, and a greater than 14% amputation rate with a functioning
graft.6,20-32 Based on these parameters alone, more than one-third of ESRD
patients undergoing IABG will have an unacceptable outcome. This sobering
figure does not take into account the morbidity and mortality of subsequent
amputation and the fact that almost half of these patients will not survive
beyond 2 years. In addition, of those patients undergoing &dquo;successful&dquo; IABG,
not all will achieve ambulatory independence-only 31% in one of the most
recently published series.32
The results of IABG in ESRD patients are so poor that primary amputa-
tion may seem an attractive alternative. Previously, it has been reported that
ESRD amputees have similar functional independence, mortality, prosthetic
rehabilitation, and cost compared with their non-ESRD counterparts.34
However, mortality associated with amputation in this population has been
high,’ and amputation clearly deprives some patients from the benefits of
IABG. The key for improving results is to establish firm guidelines for arter-
ial reconstruction and to move directly to amputation in those patients with
little or no chance for limb salvage.
CONCLUSION
Patients with ESRD probably represent the single most challenging group of
patients vascular surgeons are called upon to treat for critical limb ischemia.
Results following IABG are far inferior to those in non-ESRD patients. The
greatest limitation to acceptable limb salvage in this group is ongoing tissue
loss/infection despite a hemodynamically functioning bypass graft. Preoper-
ative factors such as extent of infection, presence of heel ulcers, and poor
pedal runoff may help distinguish those patients better served by primary
amputation. Further studies to validate the accuracy of current predictors and
to develop new ones are desperately needed. Because of the limited number
of patients at any one center, the fastest way to accrue such information may
be through the creation of a national database. Future research should focus
on outcomes other than limb salvage; careful analysis of quality of life para-
meters, ambulatory status, function, and cost-benefit ratios are essential to
develop firm guidelines for IABG in ESRD. Only then can vascular surgeons
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